← back to search

Feng‐Wei Wang

Beijing Tongren Hospital · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Circular RNAs in diseases, Epigenetics and DNA Methylation, RNA modifications and cancer, and MicroRNA in disease regulation.
h-index
16
citations
1,738
works
38
NIH funding
primary concept
email

Recent publications

Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma
Drug Resistance Updates 2024cited by 49position: middledoi
Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy
Signal Transduction and Targeted Therapy 2024cited by 34position: lastdoi
A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma
Molecular Cancer 2022cited by 138position: middledoi
KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming
Molecular Therapy 2022cited by 17position: lastdoi
A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation
Molecular Cancer 2021cited by 111position: middledoi
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis: Erratum
Theranostics 2021cited by 12position: middledoi
Correction: LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization
Cell Death and Disease 2020cited by 208position: middledoi
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17
Molecular Cancer 2020cited by 189position: middledoi
Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma
Theranostics 2020cited by 54position: middledoi
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
Nature Communications 2019cited by 836position: middledoi
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis
Theranostics 2019cited by 257position: middledoi
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis
Molecular Therapy 2019cited by 177position: middledoi
APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production
Journal of Clinical Investigation 2018cited by 168position: firstdoi
MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy
Cancer Letters 2012cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dan Xie · Capital Medical University12 papers (2012–2024)Rui‐Hua Xu · Henan Medical University5 papers (2018–2021)Rixin Chen · Sun Yat-sen University Cancer Center5 papers (2019–2024)Kai Han · China Agricultural University5 papers (2018–2022)Jing‐Ping Yun · Sun Yat-sen University4 papers (2019–2021)Xiaodan Ma · Sun Yat-sen University4 papers (2020–2024)Ping Lan · Sun Yat-sen University4 papers (2019–2021)Jiewei Chen · Sun Yat-sen University4 papers (2019–2024)Xin‐Yuan Guan · Chongqing Jiaotong University3 papers (2018–2020)Shi-Hui Hao · Sun Yat-sen University3 papers (2022–2024)Jin‐Ling Duan · Jiangxi University of Traditional Chinese Medicine3 papers (2020–2022)Jiaxing Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2012–2019)Xiao-Han Jin · Yunnan University3 papers (2018–2020)Muyan Cai · Guardant (United States)3 papers (2020–2024)Tuo Hu · Renmin Hospital of Wuhan University2 papers (2019–2020)Jinghua Cao · Huazhong Agricultural University2 papers (2022–2024)Ling Han · Guangzhou University of Chinese Medicine2 papers (2020–2020)Xianrui Wu · University of Shanghai for Science and Technology2 papers (2020–2021)Shuidan Xu · Sun Yat-sen University2 papers (2022–2024)Xiao‐Peng Tian · Sun Yat-sen University2 papers (2019–2021)